uPAR, MMP14, RhoC, and RhoA have been reported to be targets of miR-23a.38 MMP14 seems to regulate the expression levels of MMP2 and MMP9 in inflammatory breast cancer.47 Notably, our findings suggest that the miR-23a-HOXD10 axis is a novel regulator of the expression of Snail, Slug, and E-cadherin, which are GMT-regulated genes in GBM. The gene discussed is MMP9; the disease is glioblastoma.